NORTH READING, Mass., Jan. 8, 2020 /PRNewswire/ — TraceLink Inc., a network-based platform company with the world’s largest integrated digital supply network for life sciences, today announced that Shabbir Dahod, president and CEO of TraceLink, will present at the 38th Annual J.P. Morgan Healthcare Conference for the fourth consecutive year. His presentation will take place on Tuesday, January 14, at 5 p.m. PST at the Westin St. Francis in San Francisco.
During his presentation, Dahod will discuss the long-term global market opportunity for TraceLink’s Digital Network Platform, including the Company’s expansion into additional business areas and offerings, including Networked Health, Intelligent Supply Network, Smart Supply and Logistic, and End-to-End Supply Network Digitalization solutions, and TraceLink’s unique position in transforming the healthcare industry with its patient-centric digital supply network.
About TraceLink
TraceLink is a network-based platform company that leverages its digital supply network and digital network platform to bend the supply chain around the patient. Through its industry-leading digital supply network, the TraceLink Digital Network Platform can enable seamless data sharing and process orchestration across the entire healthcare industry, enabling the creation of a real-time, patient-driven supply network. Leading life science companies, hospitals and retail pharmacies trust TraceLink to deliver complete global connectivity, visibility and traceability of pharmaceuticals, ensuring that every patient gets the medicines they need, when they need them, safely and securely. For more information on TraceLink and our solutions, visit www.tracelink.com.
TraceLink is funded by Georgian Partners, Willett Advisors LLC, Vulcan Capital, Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
View original content:http://www.prnewswire.com/news-releases/tracelink-to-present-at-the-38th-annual-jp-morgan-healthcare-conference-300983285.html
SOURCE TraceLink
Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…